keyword
https://read.qxmd.com/read/33098742/cyanide-bridged-platinum-iron-complexes-as-cisplatin-prodrug-systems-design-and-computational-study
#1
Ariela W Kaspi-Kaneti, Srijana Bhandari, Alexander Schubert, Songping Huang, Barry Dunietz
The potential role of cyanide-bridged platinum-iron complexes as novel anti-cancer Pt(IV) prodrug is studied.  We present design  principles of a dual-functional prodrug that can release up to six  cisplatin agents per prodrug unit concurrently with a ferricyanide. The functionality of the prodrug is addressed through density functional theory (DFT) calculations. The predicted effective prodrug molecule is a unique hepta-metal center complex consisting of a ferricyanide core with the six cyano ligands each bridging through  ligand bond a Pt(IV) center...
October 24, 2020: Chemphyschem: a European Journal of Chemical Physics and Physical Chemistry
https://read.qxmd.com/read/33098725/radiographic-features-and-poor-prognostic-factors-of-interstitial-lung-disease-with-nivolumab-for-non-small-cell-lung-cancer
#2
Yoshinobu Saito, Shinichi Sasaki, Katsunori Oikado, Junya Tominaga, Masafumi Sata, Fumikazu Sakai, Terufumi Kato, Tae Iwasawa, Hirotsugu Kenmotsu, Masahiko Kusumoto, Tomohisa Baba, Masahiro Endo, Yutaka Fujiwara, Hiroaki Sugiura, Noriyo Yanagawa, Yoshihiko Ito, Takahiko Sakamoto, Yuichiro Ohe, Kazuyoshi Kuwano
Nivolumab can cause interstitial lung disease (ILD), which may be fatal; however, mortality risk factors have not been identified. This post-marketing study evaluated the poor prognostic factors of ILD in nivolumab-treated patients with non-small cell lung cancer (NSCLC) in Japan. Clinical and chest imaging findings for each ILD case were assessed by an Expert Central Review Committee, and prognosis was evaluated by radiographic findings, including the presence/absence of peritumoral ground glass opacity (peritumoral-GGO)...
October 24, 2020: Cancer Science
https://read.qxmd.com/read/33098714/drug-interaction-of-ningetinib-and-gefitinib-involving-cyp1a1-and-efflux-transporters-in-non-small-cell-lung-cancer-patients
#3
Lu Liu, Qian Wang, Cen Xie, Ning Xi, Zitao Guo, Ming Li, Xiangyu Hou, Ningjie Xie, Mingming Sun, Jing Li, Xiaoyan Chen
AIMS: Ningetinib is a tyrosine kinase inhibitor for the treatment of non-small cell lung cancer (NSCLC). The present study aims to investigate the drug interaction of ningetinib and gefitinib and the mechanism of high plasma exposure of N-demethylated ningetinib (M1) in NSCLC patients. METHODS: Patients with NSCLC were recruited. Metabolism and transport assays were performed using in vitro models. Deuterated M1 was used to study the effects of ningetinib and gefitinib on M1 efflux in ICR mice...
October 24, 2020: British Journal of Clinical Pharmacology
https://read.qxmd.com/read/33098683/rnf43-mutation-analysis-in-serrated-polyposis-sporadic-serrated-polyps-and-lynch-syndrome-polyps
#4
Y J van Herwaarden, L M Koggel, F Simmer, M E Vink-Börger, P Dura, G A Meijer, F M Nagengast, N Hoogerbrugge, T M Bisseling, I D Nagtegaal
INTRODUCTION AND AIM: RNF43 is suggested to be involved in the serrated pathway towards colorectal cancer and encodes a transmembrane Ring-type E3 ubiquitin ligase that negatively regulates the Wnt pathway. This study aims to elucidate the role of RNF43 gene variants in serrated polyposis syndrome (SPS) and serrated polyps. METHODS: Three cohorts were tested. The first cohort included germline DNA of 26 SPS patients tested for pathogenic variants in RNF43 by Sanger sequencing all exons...
October 24, 2020: Histopathology
https://read.qxmd.com/read/33098668/human-cxcr5-pd-1-cd8-t-cells-in-healthy-individuals-and-patients-with-hematologic-malignanciesvan-bruggen
#5
Tom Hofland, Anne W J Martens, Jaco A C van Bruggen, Renate de Boer, Sjoerd Schetters, Ester B M Remmerswaal, Frederike J Bemelman, Mark-David Levin, Adriaan D Bins, Eric Eldering, Arnon P Kater, Sanne H Tonino
Immune checkpoint blockade (ICB) has revolutionized cancer therapy, but varying response rates illustrate the need for biomarkers of response. Studies in mice have identified a subset of CD8 T cells that is essential for response to PD-1 ICB. These CD8 T cells co-express CXCR5, PD-1 and Tcf1, and provide effector T cells upon PD-1 ICB. It is unknown whether similar T cells play a role in PD-1 ICB in humans. We studied human peripheral blood (PB) and lymph nodes (LN) for the frequency, phenotype and functionality of CXCR5+ PD-1+ CD8 T cells...
October 24, 2020: European Journal of Immunology
https://read.qxmd.com/read/33098639/mir-140-3p-inhibits-bladder-cancer-cell-proliferation-and-invasion-by-targeting-foxq1
#6
Yuan Wang, Junwen Chen, Xia Wang, Kefeng Wang
Upregulation of the forkhead box protein Q1 ( FOXQ1 ) promotes bladder cancer (BCa) cell growth and metastasis. Factors affecting FOXQ1 expression at the post-transcriptional level have not yet been identified. We performed cell proliferation, cell invasion, and tumorigenesis experiments to characterize the relationship between FOXQ1 and miR-140-3p . We found that FOXQ1 was significantly upregulated and miR-140-3p was significantly downregulated in BCa tissues. We also identified an inverse correlation between miR-140-3p and FOXQ1 expression in BCa tissues...
October 24, 2020: Aging
https://read.qxmd.com/read/33098638/cross-talk-between-the-er-pathway-and-the-lncrna-mafg-as1-mir-339-5p-cdk2-axis-promotes-progression-of-er-breast-cancer-and-confers-tamoxifen-resistance
#7
Jing Feng, Ti Wen, Zhi Li, Liang Feng, Lu Zhou, Zichang Yang, Lu Xu, Sha Shi, Kezuo Hou, Jiming Shen, Xu Han, Yuee Teng
Hormone receptor-positive breast cancer accounts for around 75% of breast cancers. The estrogen receptor pathway promotes tumor progression and endocrine resistance. Recently, the cross-talk between the ER signaling pathway and cell cycle regulation has been identified. It is necessary to determine the underlying molecular mechanisms involved in the ER signaling pathway and find new target genes for prognosis and drug resistance in ER+ breast cancer. In this study, lncRNA MAFG-AS1 was shown to be up-regulated and associated with poor prognosis in ER+ breast cancer...
October 24, 2020: Aging
https://read.qxmd.com/read/33098618/comprehensive-phenotyping-of-dendritic-cells-in-cancer-patients-by-flow-cytometry
#8
Claudia Carenza, Sara Franzese, Francesca Calcaterra, Domenico Mavilio, Silvia Della Bella
Dendritic cells (DCs) play a crucial role in the complex interplay between tumor cells and the immune system. During the elimination phase of cancer immunoediting, immunostimulatory DCs are critical for the control of tumor growth. During the escape phase, regulatory DCs sustain tumor tolerance and contribute to the development of the immunosuppressive tumor microenvironment that characterizes this phase. Moreover, increasing evidence indicates that DCs are also critical for the success of cancer immunotherapy...
October 24, 2020: Cytometry. Part A: the Journal of the International Society for Analytical Cytology
https://read.qxmd.com/read/33098603/an-assessment-of-poly-adp-ribose-polymerase-1-role-in-normal-and-cancer-cells
#9
REVIEW
Manoj Kumar, Rishi Kumar Jaiswal, Pramod K Yadava, Rana P Singh
Poly (ADP-ribose) polymerase (PARP) is a superfamily of 18 proteins characterized by the PARP homology domain, the catalytic domain. This catalytic domain helps in the ADP-ribosylation of various acceptor proteins using nicotinamide adenine dinucleotide (NAD+) as a donor for ADP-ribose. PARP-1 and PARP-2 carry out 80% of poly-ADP-ribosylation of cellular protein. Hence, their combined knockout results in embryonic lethality of mice. PARP-1 consists of three major domains, namely, DNA binding domain, automodification domain, and a catalytic domain...
October 24, 2020: BioFactors
https://read.qxmd.com/read/33098534/age-at-initiation-of-screening-mammography-by-family-history-of-breast-cancer-in-the-breast-cancer-surveillance-consortium
#10
Danielle D Durham, Megan C Roberts, Carly P Khan, Linn A Abraham, Robert A Smith, Karla Kerlikowske, Diana L Miglioretti
PURPOSE: Women with a first-degree family history of breast cancer (FHBC) are sometimes advised to initiate screening mammography when they are 10 years younger than the age at which their youngest relative was diagnosed, despite a lack of unambiguous evidence that this is an effective strategy. It is unknown how often this results in women initiating screening earlier (< 40 years) than screening guidelines recommend for average-risk women. METHODS: We examined screening initiation age by FHBC and age at diagnosis of the youngest relative using data collected by the Breast Cancer Surveillance Consortium on 74,838 first screening mammograms performed between 1996 and 2016...
October 24, 2020: Cancer Causes & Control: CCC
https://read.qxmd.com/read/33098518/prognostic-molecular-and-biological-characteristics-of-phyllodes-tumors-of-the-breast
#11
I K Vorotnikov, I V Vysotskaya, D A Denchik, V P Letyagin, M M Davydov, V Yu Kirsanov, E A Kim, V S Buseva
Prognosis for some histological variants of a rare breast disease, phyllodes tumors, is evaluated. The prognostic potential of some molecular biological factors significantly correlating with breast cancer prognosis is evaluated on a unique clinical material (244 cases with benign, intermediate, and malignant phyllodes tumors). The development of benign phyllodes tumor relapse directly correlated with the number of G0/1-phase cells and inversely correlated with the number of cells in the G2+M and S phases. The level of steroid hormone receptors in phyllodes tumors cannot serve as a prognostic marker predicting the disease course...
October 24, 2020: Bulletin of Experimental Biology and Medicine
https://read.qxmd.com/read/33098496/dosimetric-impact-of-natural-terrestrial-radioactivity-on-residents-of-lower-himalayas-india
#12
Sarabjot Kaur, Rohit Mehra
A comprehensive radio-ecological evaluation of soil samples of Solan and Shimla districts of Himachal Pradesh has been carried out for risk and dose assessment. Twenty-six randomly selected environmental soil samples were analysed for natural radionuclide concentrations (226 Ra, 232 Th and 40 K) using NaI(Tl) scintillator detector. The average concentration of 226 Ra, 232 Th and 40 K was observed as 37, 59 and 430 Bq kg-1 , respectively, which exceeded the worldwide average of 33, 45 and 412 Bq kg-1 reported by UNSCEAR (Sources and effects of ionizing radiation...
October 24, 2020: Environmental Geochemistry and Health
https://read.qxmd.com/read/33098494/a-systematic-review-of-health-state-utility-values-for-thyroid-cancer
#13
REVIEW
Rachel Houten, Nigel Fleeman, Eleanor Kotas, Angela Boland, Tosin Lambe, Rui Duarte
PURPOSE: Health state utility values are commonly used to inform economic evaluations and determine the cost-effectiveness of an intervention. The aim of this systematic review is to summarise the utility values available to represent the health-related quality of life (HRQoL) of patients with thyroid cancer. METHODS: Eight electronic databases were searched from January 1999 to April 2019 for studies which included assessment of HRQoL for patients with thyroid cancer...
October 24, 2020: Quality of Life Research
https://read.qxmd.com/read/33098489/scoring-systems-for-pd-l1-expression-and-their-prognostic-impact-in-patients-with-resectable-gastric-cancer
#14
Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, André Roncon Dias, Renan Ribeiro, Leonardo Cardili, Bruno Zilberstein, Ivan Cecconello, Ulysses Ribeiro, Evandro Sobroza de Mello, Tiago Biachi de Castria
The combined positive score (CPS) and tumor proportion score (TPS) have been developed to evaluate programmed death ligand-1 (PD-L1) expression, especially due to the potential benefit of the targeted therapy. However, the prognostic value of PD-L1 scoring systems in gastric cancer (GC) remains unclear. This study aimed to evaluate PD-L1 expression according to CPS and TPS in curative resected GC patients and its correlation with prognosis. We retrospectively evaluated 284 GC patients who underwent D2-gastrectomy by tissue microarray...
October 24, 2020: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/33098486/sox2-sall4-stemness-axis-modulates-notch-signaling-genes-to-maintain-self-renewal-capacity-of-esophageal-squamous-cell-carcinoma
#15
Mohammad Mahdi Forghanifard, Paniz Kasebi, Mohammad Reza Abbaszadegan
Stemness phenotype is considered as the centerpiece of cancer biology due to its potential in conventional chemo-radiotherapy resistance and tumor recurrence after clinical intervention. This feature in tumor mass belongs to activation of core regulatory stemness factors and different cell signaling pathways in cancer stem cells. We aimed in this study to elucidate contribution of Notch signaling pathway in stemness state of esophageal squamous cell carcinoma (ESCC) through their relevance with stem cell markers SOX2 and SALL4...
October 24, 2020: Molecular and Cellular Biochemistry
https://read.qxmd.com/read/33098471/phase-1-study-of-gemcitabine-nab-paclitaxel-s-1-in-patients-with-unresectable-pancreatic-cancer-genes1s-trial
#16
Satoshi Sai, Masanori Toyoda, Kazutoshi Tobimatsu, Hironaga Satake, Hisateru Yasui, Shiro Kimbara, Taiji Koyama, Yoshimi Fujishima, Yoshinori Imamura, Yohei Funakoshi, Naomi Kiyota, Hirochika Toyama, Yuzo Kodama, Hironobu Minami
PURPOSE: We conducted a phase 1 study to determine the maximum tolerated dose and the recommended dose of gemcitabine/nab-paclitaxel/S-1 combination chemotherapy in patients with unresectable pancreatic cancer. METHODS: We enrolled patients aged 20 years or older with unresectable pancreatic cancer and who had not been treated with chemotherapy or radiation therapy. Gemcitabine and nab-paclitaxel were administered on days 1 and 8, and S-1 was administered orally twice daily for 2 weeks, repeated every 3 weeks...
October 24, 2020: Cancer Chemotherapy and Pharmacology
https://read.qxmd.com/read/33098447/the-clinical-relevance-of-the-hippo-pathway-in-pancreatic-ductal-adenocarcinoma
#17
Richard Drexler, Mirco Küchler, Kim C Wagner, Tim Reese, Bernd Feyerabend, Moritz Kleine, Karl J Oldhafer
PURPOSE: The Hippo pathway has broadened in cancer research in the past decade and revealed itself to be an important driver for tumorigenesis and metastatic spread. In this study, we investigated the clinical relevance of the Hippo pathway with regard to metastatic invasion, patients' outcome and histopathological features. METHODS: Protein expression of components of the Hippo pathway were analyzed by immunohistochemistry (IHC) using paraffin-embedded tissue from 103 patients who had been diagnosed with pancreatic ductal adenocarcinoma and had undergone surgery...
October 24, 2020: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/33098378/loganetin-and-5-fluorouracil-synergistically-inhibit-the-carcinogenesis-of-gastric-cancer-cells-via-down-regulation-of-the-wnt-%C3%AE-catenin-pathway
#18
Huaixiang Zhou, Xiaoge Hu, Na Li, Guangyan Li, Xiaotian Sun, Feimin Ge, Jiahong Jiang, Jingchun Yao, Dongsheng Huang, Liu Yang
Although most gastrointestinal tumours are sensitive to 5-fluorouracil (5FU), drug resistance is commonly occurred after 5FU therapy in gastric cancer (GC). Loganetin is the primary active compound in Cornus officinali. However, the synergetic effects of loganetin and 5FU on GC remain unknown. Here, we investigated the synergetic effects and the underlying mechanism of loganetin and 5FU on proliferation, stem-like properties, migration, and invasion of GC both in vitro and in vivo. We found that loganetin alone inhibited the proliferation, stem-like properties, migration and invasion of GC cells in vitro...
October 24, 2020: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/33098374/proteome-analyses-reveal-s100a11-s100p-and-rbm25-are-tumor-biomarkers-in-colorectal-cancer
#19
Ai-Jun Guo, Feng-Jie Wang, Qiang Ji, Hui-Wu Geng, Xu Yan, Lin-Qi Wang, Wei-Wei Tie, Xiao-Ying Liu, Rick F Thorne, Gang Liu, A-Man Xu
PURPOSE: The prognosis for colorectal cancer (CRC) patients is drastically impacted by the presence of lymph node or liver metastases at diagnosis or resection. On this basis we sought to identify novel proteins as biomarkers and determinants of CRC metastasis. EXPERIMENTAL DESIGN: Proteomic analyses were undertaken using primary tissues from ten Chinese CRC patients presenting with or without liver metastases and immunohistochemistry used to validate selected proteins in an independent patient cohort...
October 24, 2020: Proteomics. Clinical Applications
https://read.qxmd.com/read/33098372/modified-j-capra-scoring-system-in-predicting-treatment-outcomes-of-metastatic-prostate-cancer-patients-undergoing-androgen-deprivation-therapy
#20
Jasmine Lim, Shiro Hinotsu, Mizuki Onozawa, Rohan Malek, Murali Sundram, Guan C Teh, Teng-Aik Ong, Shankaran Thevarajah, Rohana Zainal, Say C Khoo, Shamsuddin Omar, Noor A Nasuha, Hideyuki Akaza
The J-CAPRA score is an assessment tool which stratifies risk and predicts outcome of primary androgen deprivation therapy (ADT) using prostate-specific antigen, Gleason score, and clinical TNM staging. Here, we aimed to assess the generalisability of this tool in multi-ethnic Asians. Performance of J-CAPRA was evaluated in 782 Malaysian and 16,946 Japanese patients undergoing ADT from the Malaysian Study Group of Prostate Cancer (M-CaP) and Japan Study Group of Prostate Cancer (J-CaP) databases, respectively...
October 24, 2020: Cancer Medicine
keyword
keyword
302
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"